Table 1.
Diagnosis | p63 | p40 | ||||
---|---|---|---|---|---|---|
Focal | Diffuse | Any positivity | Focal | Diffuse | Any positivity | |
Epithelial | ||||||
Squamous cell carcinoma | 1/67 (1) | 65/67 (97) | 66/67 (99) | 1/67 (1) | 65/67 (97) | 66/67 (99) |
Sinonasal undifferentiated carcinoma | 2/11 (18) | 4/11 (36) | 6/11 (55) | 2/11 (18) | 4/11 (36) | 6/11 (55) |
Nasopharyngeal carcinoma | 0/6 (0) | 6/6 (100) | 6/6 (100) | 0/6 (0) | 6/6 (100) | 6/6 (100) |
Solid adenoid cystic carcinoma | 2/4 (50) | 0/4 (0) | 2/4 (50) | 2/4 (50) | 0/4 (0) | 2/4 (50) |
NUT midline carcinoma | 0/4 (0) | 3/4 (75) | 3/4 (75) | 3/4 (75) | 0/4 (0) | 3/4 (75) |
Neuroectodermal | ||||||
Esthesioneuroblastoma | 15/46 (33) | 1/46 (2) | 16/46 (35) | 12/46 (26) | 1/46 (2) | 13/46 (28) |
Ewing sarcoma/PNET | 0/4 (0) | 2/4 (50) | 2/4 (50) | 0/4 (0) | 1/4 (24) | 1/4 (25) |
Small cell carcinoma | 1/2 (50) | 0/2 (0) | 1/2 (50) | 1/2 (50) | 0/2 (0) | 1/2 (50) |
Melanoma | 0/9 (0) | 0/9 (0) | 0/9 (0) | 0/9 (0) | 0/9 (0) | 0/9 (0) |
Hematolymphoid | ||||||
NK/T cell | 2/4 (50) | 0/4 (0) | 2/4 (50) | 0/4 (0) | 0/4 (0) | 0/4 (0) |
Diffuse large B cell | 0/7 (0) | 3/7 (43) | 3/7 (43) | 0/7 (0) | 0/7 (0) | 0/7 (0) |
Mesenchymal | ||||||
Alveolar rhabdomyosarcoma | 4/7 (57) | 0/7 (0) | 4/7 (57) | 0/7 (0) | 0/7 (0) | 0/7 (0) |